CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Country • United States
    Entity • country not supported, please select another country
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Perdagangan Angion Biomedica Corp. - ANGN CFD

    0.5178
    6.81%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.0644
    Biaya inap posisi Long

    Long position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight -0.024874 %
    Charges from borrowed part ($-0.99)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		-0.024874%
    Biaya inap posisi short

    Short position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight 0.002651 %
    Charges from borrowed part ($0.11)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		0.002651%
    Waktu biaya inap 21:00 (UTC)
    Kuantitas min. yang diperdagangkan 1
    Mata uang USD
    Margin 20%
    Bursa efek United States of America
    Komisi perdagangan 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 0.4848
    Open* 0.5402
    1-Year Change* -72.58%
    Day's Range* 0.5014 - 0.5471
    52 wk Range 0.46-2.37
    Average Volume (10 days) 17.70K
    Average Volume (3 months) 1.40M
    Market Cap 15.32M
    P/E Ratio -100.00K
    Shares Outstanding 30.11M
    Revenue 2.30M
    EPS -1.29
    Dividend (Yield %) N/A
    Beta -100.00K
    Next Earnings Date Mar 31, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Mar 30, 2023 0.4848 0.0072 1.51% 0.4776 0.5475 0.4688
    Mar 29, 2023 0.4887 0.0197 4.20% 0.4690 0.4887 0.4688
    Mar 28, 2023 0.4642 -0.0146 -3.05% 0.4788 0.4788 0.4642
    Mar 27, 2023 0.4799 0.0009 0.19% 0.4790 0.5252 0.4786
    Mar 24, 2023 0.4885 -0.0390 -7.39% 0.5275 0.5276 0.4884
    Mar 23, 2023 0.5307 0.0028 0.53% 0.5279 0.5374 0.5238
    Mar 22, 2023 0.4887 0.0096 2.00% 0.4791 0.4890 0.4791
    Mar 21, 2023 0.4789 0.0248 5.46% 0.4541 0.4791 0.4493
    Mar 20, 2023 0.4881 0.0001 0.02% 0.4880 0.4986 0.4739
    Mar 17, 2023 0.4887 -0.0490 -9.11% 0.5377 0.5378 0.4823
    Mar 16, 2023 0.5081 0.0198 4.05% 0.4883 0.5695 0.4883
    Mar 15, 2023 0.4930 -0.0542 -9.90% 0.5472 0.5671 0.4888
    Mar 14, 2023 0.5372 -0.0196 -3.52% 0.5568 0.5963 0.5372
    Mar 13, 2023 0.5377 -0.0240 -4.27% 0.5617 0.5621 0.5208
    Mar 10, 2023 0.5132 -0.0641 -11.10% 0.5773 0.5778 0.5054
    Mar 9, 2023 0.5568 -0.0604 -9.79% 0.6172 0.6256 0.5375
    Mar 8, 2023 0.5960 0.0078 1.33% 0.5882 0.6158 0.5882
    Mar 7, 2023 0.6060 -0.0094 -1.53% 0.6154 0.6155 0.6056
    Mar 6, 2023 0.6256 -0.0208 -3.22% 0.6464 0.6466 0.6079
    Mar 3, 2023 0.6156 0.0290 4.94% 0.5866 0.6258 0.5865

    Angion Biomedica Corp. Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 2.301 28.312 2.88 1.487 4.029
    Revenue 2.301 28.312 2.88 1.487 4.029
    Cost of Revenue, Total 0 0.433 1.19 0.64 0.378
    Gross Profit 2.301 27.879 1.69 0.847 3.651
    Total Operating Expense 41.922 66.714 58.153 40.078 18.371
    Selling/General/Admin. Expenses, Total 14.637 18.488 17.986 9.601 5.391
    Research & Development 18.1 48.698 38.977 29.837 12.602
    Operating Income -39.621 -38.402 -55.273 -38.591 -14.342
    Interest Income (Expense), Net Non-Operating 0.719 -2.191 -8.249 0.488 0.401
    Other, Net 0.095 -13.98 -16.527 -2.555 -6.084
    Net Income Before Taxes -38.807 -54.573 -80.107 -40.658 -20.025
    Net Income After Taxes -38.807 -54.573 -80.107 -40.658 -20.025
    Net Income Before Extra. Items -38.807 -54.573 -80.107 -40.658 -20.025
    Net Income -38.807 -54.573 -80.107 -40.658 -20.025
    Total Adjustments to Net Income 0 -4.98
    Income Available to Common Excl. Extra. Items -38.807 -54.573 -80.107 -40.658 -25.005
    Income Available to Common Incl. Extra. Items -38.807 -54.573 -80.107 -40.658 -25.005
    Diluted Net Income -38.807 -54.573 -80.107 -40.658 -25.005
    Diluted Weighted Average Shares 30.0407 28.2448 14.7621 9.97635 9.97635
    Diluted EPS Excluding Extraordinary Items -1.29181 -1.93214 -5.42652 -4.07544 -2.50643
    Dividends per Share - Common Stock Primary Issue 0 0
    Diluted Normalized EPS -0.98606 -1.96418 -5.4226 -4.07544 -2.50643
    Gain (Loss) on Sale of Assets 0 -0.058
    Unusual Expense (Income) 9.185 -0.905
    Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
    Total revenue 0 0 0.653 1.648 25.941
    Revenue 0 0 0.653 1.648 25.941
    Cost of Revenue, Total 0.433
    Gross Profit 25.508
    Total Operating Expense 7.051 9.05 9.688 16.133 11.307
    Selling/General/Admin. Expenses, Total 3.745 3.315 3.615 4.466 4.206
    Research & Development 0.16 2.938 6.073 11.667 6.668
    Operating Income -7.051 -9.05 -9.035 -14.485 14.634
    Interest Income (Expense), Net Non-Operating 0.606 0.053 -0.146 0.206 -0.016
    Other, Net 0.005 0.009 0.042 0.039 0.272
    Net Income Before Taxes -6.44 -8.988 -9.139 -14.24 14.89
    Net Income After Taxes -6.44 -8.988 -9.139 -14.24 14.89
    Net Income Before Extra. Items -6.44 -8.988 -9.139 -14.24 14.89
    Net Income -6.44 -8.988 -9.139 -14.24 14.89
    Income Available to Common Excl. Extra. Items -6.44 -8.988 -9.139 -14.24 14.89
    Income Available to Common Incl. Extra. Items -6.44 -8.988 -9.139 -14.24 14.89
    Diluted Net Income -6.44 -8.988 -9.139 -14.24 14.89
    Diluted Weighted Average Shares 30.1146 30.1134 29.9739 29.9592 29.9654
    Diluted EPS Excluding Extraordinary Items -0.21385 -0.29847 -0.3049 -0.47531 0.49691
    Dividends per Share - Common Stock Primary Issue 0 0 0
    Diluted Normalized EPS -0.10938 -0.20559 -0.3049 -0.47531 0.49691
    Unusual Expense (Income) 3.146 2.797 0 0
    Gain (Loss) on Sale of Assets 0
    • Annual
    • Quarterly
    2021 2020 2019 2018
    Total Current Assets 91.247 42.297 6.106 25.679
    Cash and Short Term Investments 88.756 34.607 5.571 25.512
    Cash & Equivalents 88.756 34.607 5.571 25.512
    Total Receivables, Net 0.806 5 0.44 0.107
    Prepaid Expenses 1.031 0.352 0.095 0.06
    Total Assets 96.513 47.347 11.886 26.628
    Property/Plant/Equipment, Total - Net 4.437 4.228 4.781 0.017
    Property/Plant/Equipment, Total - Gross 4.954 4.654 5.109 0.295
    Accumulated Depreciation, Total -0.517 -0.426 -0.328 -0.278
    Long Term Investments 0.723 0.822 0.999 0.932
    Total Current Liabilities 11.296 107.449 26.575 7.355
    Accounts Payable 4.71 5.578 11.239 0.534
    Accrued Expenses 4.113 7.276 3.694 2.98
    Notes Payable/Short Term Debt 0 51.43 5.848 0
    Other Current Liabilities, Total 2.415 43.165 5.794 3.841
    Total Liabilities 15.006 137.796 30.472 7.717
    Total Long Term Debt 0.235 0.635 0 0
    Other Liabilities, Total 3.475 29.712 3.897 0.362
    Total Equity 81.507 -90.449 -18.586 18.911
    Preferred Stock - Non Redeemable, Net 0 0 0
    Common Stock 0.3 0.156 0.095 0.094
    Additional Paid-In Capital 296.445 72.136 63.584 60.138
    Retained Earnings (Accumulated Deficit) -215.135 -160.562 -80.455 -39.797
    Treasury Stock - Common 0 -1.846 -1.81 -1.524
    Total Liabilities & Shareholders’ Equity 96.513 47.347 11.886 26.628
    Total Common Shares Outstanding 29.9591 15.3167 9.97635 9.97635
    Other Current Assets, Total 0.654 2.338
    Long Term Debt 0 0.635
    Other Equity, Total -0.103 -0.333
    Other Long Term Assets, Total 0.106
    Current Port. of LT Debt/Capital Leases 0.058
    Capital Lease Obligations 0.235
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Total Current Assets 76.239 91.247 104.393 119.702 133.498
    Cash and Short Term Investments 73.002 88.756 102.736 117.313 130.456
    Cash & Equivalents 73.002 88.756 102.736 117.313 130.456
    Total Receivables, Net 0 0.806 0 0 0
    Prepaid Expenses 0.021 1.031 1.018 1.761 2.343
    Other Current Assets, Total 3.216 0.654 0.639 0.628 0.699
    Total Assets 81.258 96.513 109.94 125.359 139.2
    Property/Plant/Equipment, Total - Net 4.209 4.437 4.652 4.776 4.787
    Property/Plant/Equipment, Total - Gross 4.758 4.954 5.137 5.231 5.219
    Accumulated Depreciation, Total -0.549 -0.517 -0.485 -0.455 -0.432
    Long Term Investments 0.732 0.723 0.862 0.843 0.877
    Other Long Term Assets, Total 0.078 0.106 0.033 0.038 0.038
    Total Current Liabilities 10.381 11.296 17.946 20.524 16.963
    Accounts Payable 3.433 4.71 7.679 9.307 6.69
    Accrued Expenses 6.16 4.113 6.219 5.522 4.872
    Notes Payable/Short Term Debt 0 0 0 0 0.895
    Other Current Liabilities, Total 0.728 2.415 4.048 5.695 4.506
    Total Liabilities 14.056 15.006 45.426 48.17 46.757
    Total Long Term Debt 0.219 0.235 0 0 0
    Long Term Debt 0 0 0 0
    Other Liabilities, Total 3.456 3.475 27.48 27.646 29.794
    Total Equity 67.202 81.507 64.514 77.189 92.443
    Common Stock 0.3 0.3 0.304 0.303 0.3
    Additional Paid-In Capital 296.476 296.445 298.518 295.636 292.67
    Retained Earnings (Accumulated Deficit) -229.375 -215.135 -230.025 -214.321 -197.249
    Treasury Stock - Common 0 -4.21 -4.21 -2.991
    Other Equity, Total -0.199 -0.103 -0.073 -0.219 -0.287
    Total Liabilities & Shareholders’ Equity 81.258 96.513 109.94 125.359 139.2
    Total Common Shares Outstanding 29.9594 29.9591 29.9331 29.7976 29.6605
    Current Port. of LT Debt/Capital Leases 0.06 0.058
    Capital Lease Obligations 0.219 0.235
    • Annual
    • Quarterly
    2021 2020 2019 2018
    Net income/Starting Line -54.573 -80.107 -40.658 -20.025
    Cash From Operating Activities -52.643 -22.888 -24.589 -8.02
    Cash From Operating Activities 0.091 0.098 0.05 0.002
    Non-Cash Items 27.809 31.352 6.269 9.051
    Cash Taxes Paid 0 0
    Cash Interest Paid 0.007 0 0
    Changes in Working Capital -25.97 25.769 9.75 2.952
    Cash From Investing Activities -0.382 -0.041 -0.242 0
    Capital Expenditures -0.382 -0.041 -0.242 0
    Cash From Financing Activities 107.171 52.409 4.89 31.741
    Issuance (Retirement) of Stock, Net -0.617 20.813 -0.375 28.596
    Issuance (Retirement) of Debt, Net 0.293 32.118 5.265 3.145
    Net Change in Cash 54.149 29.036 -19.941 23.721
    Financing Cash Flow Items 107.495 -0.522
    Foreign Exchange Effects 0.003 -0.444
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Net income/Starting Line -14.24 -54.573 -69.463 -53.759 -36.687
    Cash From Operating Activities -15.653 -52.643 -38.281 -23.082 -12.551
    Cash From Operating Activities 0.032 0.091 0.059 0.029 0.006
    Non-Cash Items 0.179 27.809 25.729 23.505 21.675
    Changes in Working Capital -1.624 -25.97 5.394 7.143 2.455
    Cash From Investing Activities 0 -0.382 -0.346 -0.285 -0.041
    Capital Expenditures 0 -0.382 -0.346 -0.285 -0.041
    Cash From Financing Activities -0.014 107.171 106.767 106.068 108.444
    Financing Cash Flow Items 0 107.495 -5.52 -5.428 -2.797
    Issuance (Retirement) of Stock, Net 0 -0.617 112.287 111.496 111.241
    Issuance (Retirement) of Debt, Net -0.014 0.293 0 0 0
    Foreign Exchange Effects -0.087 0.003 -0.011 0.005 -0.003
    Net Change in Cash -15.754 54.149 68.129 82.706 95.849
    Cash Interest Paid 0.007
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Satterfield (Thomas A Jr) Individual Investor 7.2983 2197825 623278 2022-12-31 LOW
    Vifor (International), Ltd Corporation 6.6269 1995643 0 2023-03-15 LOW
    EISA-ABC LLC Corporation 5.719 1722237 0 2023-03-15 LOW
    Goldberg (Itzhak D) Individual Investor 5.6193 1692199 4213 2023-03-15 LOW
    Venkatesan (Jay R) Individual Investor 3.9765 1197498 0 2023-03-15 LOW
    BVF Partners L.P. Hedge Fund 3.5574 1071297 0 2022-12-31 LOW
    Nantahala Capital Management, LLC Hedge Fund 3.4308 1033145 -32867 2022-12-31 MED
    Ganzi (Victor F.) Individual Investor 3.25 978698 0 2023-03-15 LOW
    CM Management, LLC Investment Advisor 2.4313 732178 132178 2022-12-31 MED
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.1386 644035 675 2022-12-31 LOW
    Park West Asset Management LLC Hedge Fund 1.2311 370724 0 2022-12-31 MED
    Bridgeway Capital Management, LLC Investment Advisor 0.5811 175000 0 2022-12-31 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5593 168436 -451 2022-12-31 LOW
    Renaissance Technologies LLC Hedge Fund 0.4041 121700 -87277 2022-12-31 HIGH
    Omenn (Gilbert S) Individual Investor 0.2667 80326 0 2023-03-15 LOW
    Millennium Management LLC Hedge Fund 0.2502 75342 -50261 2022-12-31 HIGH
    Raymond James & Associates, Inc. Research Firm 0.1992 60000 0 2022-12-31 LOW
    Birchview Capital, LP Investment Advisor 0.1806 54392 0 2022-12-31 LOW
    Ergoteles Capital Hedge Fund 0.1757 52913 -25944 2022-12-31 HIGH
    BlackRock Institutional Trust Company, N.A. Investment Advisor 0.1696 51069 1188 2022-12-31 LOW

    Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

    Capital.com Group

    500K+

    Trader

    92K+

    Klien aktif per bulan

    $53M+

    Volume investasi per bulan

    $30M+

    Penarikan tiap bulan

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Laba/Loss
    Industry: Biotechnology & Medical Research (NEC)

    7-57 Wells Avenue
    NEWTON
    MASSACHUSETTS 02459
    US

    Income Statement

    • Annual
    • Quarterly

    People also watch

    Gold

    1,969.66 Price
    -0.550% 1D Chg, %
    Biaya inap posisi Long -0.0185%
    Biaya inap posisi short 0.0102%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.30

    Natural Gas

    2.20 Price
    +3.540% 1D Chg, %
    Biaya inap posisi Long -0.4044%
    Biaya inap posisi short 0.3825%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.005

    Oil - Crude

    75.76 Price
    +1.830% 1D Chg, %
    Biaya inap posisi Long -0.0156%
    Biaya inap posisi short -0.0063%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.03

    US100

    13,186.80 Price
    +1.680% 1D Chg, %
    Biaya inap posisi Long -0.0249%
    Biaya inap posisi short 0.0027%
    Waktu biaya inap 21:00 (UTC)
    Spread 3.0

    Masih mencari broker yang bisa Anda percayai?

    Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

    1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda